Thermo Fisher Scientific, Inc. (NYSE: TMO) inked a supply deal with Russian firm Optec LLC to provide cancer diagnostic equipment to several hospitals across the Russian Federation.
The Waltham, Mass.-based lab instrument maker will supply its Thermo Scientific Excelsior ES to hospitals in Moscow, Penza, Kirov, Volgograd and Voronezh.
The deal is worth an estimated $2 million, according to a prepared release put out by Optec, which also acts as a distribution partner for Stryker Corp. (NYSE: SYK), according to its website.